| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Access to novel cancer medicines in four countries in Central and Eastern Europe in relation to clinical benefit
|
Hofmarcher, T.
|
|
|
8 |
4 |
p.
|
artikel
|
| 2 |
An Italian multicenter retrospective real-life analysis of patients with brain metastases from renal cell carcinoma: the BMRCC study
|
Internò, V.
|
|
|
8 |
4 |
p.
|
artikel
|
| 3 |
A phase Ib/II dose expansion study of subcutaneous sasanlimab in patients with locally advanced or metastatic non-small-cell lung cancer and urothelial carcinoma
|
Cho, B.C.
|
|
|
8 |
4 |
p.
|
artikel
|
| 4 |
A three-gene signature marks the time to locoregional recurrence in luminal-like breast cancer
|
Chiodoni, C.
|
|
|
8 |
4 |
p.
|
artikel
|
| 5 |
Avelumab or talazoparib in combination with binimetinib in metastatic pancreatic ductal adenocarcinoma: dose-finding results from phase Ib of the JAVELIN PARP MEKi trial ☆
|
Rodon Ahnert, J.
|
|
|
8 |
4 |
p.
|
artikel
|
| 6 |
Clinical, molecular, and immune correlates of the Immunotherapy Response Score in patients with advanced urothelial carcinoma under atezolizumab monotherapy: analysis of the phase II IMvigor210 trial
|
Ferreiro-Pantín, M.
|
|
|
8 |
4 |
p.
|
artikel
|
| 7 |
Comparison of clinical outcomes of osimertinib and first-generation EGFR-tyrosine kinase inhibitors (TKIs) in TKI-untreated EGFR-mutated non-small-cell lung cancer with leptomeningeal metastases
|
Tamura, K.
|
|
|
8 |
4 |
p.
|
artikel
|
| 8 |
Cracking KRASG12C across all solid tumors: the new kid on the block for tissue-agnostic precision medicine
|
Bhamidipati, D.
|
|
|
8 |
4 |
p.
|
artikel
|
| 9 |
Dignity of science and the use of ChatGPT as a co-author
|
Scimeca, M.
|
|
|
8 |
4 |
p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
|
8 |
4 |
p.
|
artikel
|
| 11 |
Evaluation of the relevance of the growth modulation index (GMI) from the FFCD 0307 randomized phase III trial comparing the sequence of two chemotherapeutic regimens
|
du Rusquec, P.
|
|
|
8 |
4 |
p.
|
artikel
|
| 12 |
Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors
|
Oosting, S.F.
|
|
|
8 |
4 |
p.
|
artikel
|
| 13 |
Impact of sex on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC). Subgroup analysis of the PanaMa-study (AIO-KRK-0212) ☆
|
Heinrich, K.
|
|
|
8 |
4 |
p.
|
artikel
|
| 14 |
Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma
|
Nakayama, I.
|
|
|
8 |
4 |
p.
|
artikel
|
| 15 |
Incidence of interstitial lung disease and cardiotoxicity with trastuzumab deruxtecan in breast cancer patients: a systematic review and single-arm meta-analysis
|
Soares, L.R.
|
|
|
8 |
4 |
p.
|
artikel
|
| 16 |
Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study
|
Charton, E.
|
|
|
8 |
4 |
p.
|
artikel
|
| 17 |
In the literature: July 2023
|
Gambardella, V.
|
|
|
8 |
4 |
p.
|
artikel
|
| 18 |
Learning lessons from the COVID-19 pandemic for real-world evidence research in oncology—shared perspectives from international consortia
|
Castelo-Branco, L.
|
|
|
8 |
4 |
p.
|
artikel
|
| 19 |
Long-acting gonadotropin-releasing hormone agonist trigger in fertility preservation cycles before chemotherapy
|
Massarotti, C.
|
|
|
8 |
4 |
p.
|
artikel
|
| 20 |
Management of patients with HER2-positive metastatic breast cancer after trastuzumab deruxtecan failure
|
Antonarelli, G.
|
|
|
8 |
4 |
p.
|
artikel
|
| 21 |
Molecular alterations and potential actionable mutations in peritoneal mesothelioma: a scoping review of high-throughput sequencing studies
|
Dietz, M.V.
|
|
|
8 |
4 |
p.
|
artikel
|
| 22 |
Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14 ☆
|
König, D.
|
|
|
8 |
4 |
p.
|
artikel
|
| 23 |
Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation
|
Gosney, J.R.
|
|
|
8 |
4 |
p.
|
artikel
|
| 24 |
Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18
|
Kim, M.
|
|
|
8 |
4 |
p.
|
artikel
|
| 25 |
Prognostic value of HER2-low status in breast cancer: a systematic review and meta-analysis
|
Molinelli, C.
|
|
|
8 |
4 |
p.
|
artikel
|
| 26 |
Ramucirumab plus erlotinib versus placebo plus erlotinib in previously untreated EGFR-mutated metastatic non-small-cell lung cancer (RELAY): exploratory analysis of next-generation sequencing results
|
Garon, E.B.
|
|
|
8 |
4 |
p.
|
artikel
|
| 27 |
Randomized phase II adjuvant trial to compare two treatment durations of icotinib (2 years versus 1 year) for stage II-IIIA EGFR-positive lung adenocarcinoma patients (ICOMPARE study) ☆
|
Lv, C.
|
|
|
8 |
4 |
p.
|
artikel
|
| 28 |
Real-world evidence of trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer using an administrative claims database in Japan ☆
|
Kagawa, Y.
|
|
|
8 |
4 |
p.
|
artikel
|
| 29 |
Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group
|
Loong, H.H.
|
|
|
8 |
4 |
p.
|
artikel
|
| 30 |
Retrospective study to estimate the prevalence and describe the clinicopathological characteristics, treatments received, and outcomes of HER2-low breast cancer ☆
|
Viale, G.
|
|
|
8 |
4 |
p.
|
artikel
|
| 31 |
Sodium fluoride (Na18F) PET Response Criteria in Solid Tumors (NAFCIST): a framework for response assessment in bone tumors
|
Kairemo, K.
|
|
|
8 |
4 |
p.
|
artikel
|
| 32 |
Table of Contents
|
|
|
|
8 |
4 |
p.
|
artikel
|
| 33 |
Use of ChatGPT as a co-author
|
Kleebayoon, A.
|
|
|
8 |
4 |
p.
|
artikel
|
Tijdschrift beschrijving